3-{[(4-chloro-6-methylpyrimidin-2-yl)amino]methylene}-1,1,1-trifluoropentane-2,4-dione

Catalog No. :
ACBKMG685
CAS No. :
649665-78-1
Molecular Formula :
C11H9ClF3N3O2
Molecular Weight :
307.66

IUPAC Name:(E)-3-(((4-chloro-6-methylpyrimidin-2-yl)amino)methylene)-1,1,1-trifluoropentane-2,4-dione

3-{[(4-chloro-6-methylpyrimidin-2-yl)amino]methylene}-1,1,1-trifluoropentane-2,4-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-{[(4-chloro-6-methylpyrimidin-2-yl)amino]methylene}-1,1,1-trifluoropentane-2,4-dione
IUPAC Name(E)-3-(((4-chloro-6-methylpyrimidin-2-yl)amino)methylene)-1,1,1-trifluoropentane-2,4-dione
MDL No.MFCD01763861
Molecular FormulaC11H9ClF3N3O2
Molecular Weight307.66
SMILESCC(=O)/C(=C\NC1=NC(C)=CC(Cl)=N1)C(=O)C(F)(F)F
InChI KeyHCPDZQTWTWHVEU-QPJJXVBHSA-N
Synonym2,4-Pentanedione, 3-[[(4-chloro-6-methyl-2-pyrimidinyl)amino]methylene]-1,1,1-trifluoro-
CAS No.649665-78-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBKMG685 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZQMI341 route compound structure diagram
    ACZQMI3415600-21-5 In Stock
  4. Then
  5. ACBKMG685 route product structure diagram
    ACBKMG685649665-78-1
Inquiry

2. ACBKMG685 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTLWF249 route compound structure diagram
    ACTLWF24914324-82-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBKMG685 route product structure diagram
    ACBKMG685649665-78-1
Inquiry

Comments (0)